Halozyme Therapeutics shares owned by Wealth Enhancement Advisory Services
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Wealth Enhancement Advisory Services
from 13F filings
Historical chart of Wealth Enhancement Advisory Services investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Wealth Enhancement Advisory Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-09-30 | $5.3M | 106k | 50.01 |
| 2026-06-30 | $1.8M | 71k | 26.06 |
| 2025-12-31 | $1.6M | 21k | 75.99 |
| 2025-09-30 | $1.4M | 21k | 66.02 |
| 2025-06-30 | $765k | 14k | 54.00 |
| 2025-03-31 | $1.3M | 21k | 63.81 |
| 2024-12-31 | $597k | 13k | 47.81 |
| 2024-06-30 | $616k | 12k | 52.36 |
| 2024-03-31 | $416k | 10k | 40.68 |
| 2023-09-30 | $367k | 9.6k | 38.20 |
More positions owned by Wealth Enhancement Advisory Services
View all positions for Wealth Enhancement Advisory Services